Motor Neurone Disease, Volume 176 in the International Review in Neurobiology serial highlights new advances, with this new volume presenting interesting chapters written by an international board of authors. Updates include chapters on Clinical features, differential diagnosis and pathology, Recent advances in genetics of familial and sporadic ALS, Non-coding genome contribution to ALS, Contribution of neurophysiology to the diagnosis and monitoring ALS, Advances in symptom management and monitoring disease progression, Use of biomarkers in clinical trials and future developments that will help identify new biomarkers, Application of systems biology to identify therapeutic targets, and much more. Additional sections cover Evidence of mitochondrial dysfunction (in ALS) and how to measure it in model systems, Current neuroprotective therapies and future prospects, The role of glial cells in ALS, Dysregulation of RNA biology in ALS, New developments in pre-clinical models of ALS to guide translation.
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Table of Contents
1. Clinical features, differential diagnosis and pathologyMichael van Es
2. Recent advances in genetics of familial and sporadic ALS
Ammar Al Chalabi
3. Non-coding genome contribution to ALS
John Cooper-Knock
4. Contribution of neurophysiology to the diagnosis and monitoring ALS
James Alix
5. Advances in symptom management and monitoring disease progression
Chris McDermott
6. Use of biomarkers in clinical trials and future developments that will help identify new biomarkers
Andrea Malaspina
7. Application of systems biology to identify therapeutic targets
Janine Kirby and Bryan Traynor
8. Evidence of mitochondrial dysfunction (in ALS) and how to measure it in model systems
Heather Mortiboys and Kurt de Vos
9. Current neuroprotective therapies and future prospects
Pamela Shaw
10. The role of glial cells in ALS
Rickie Patani
11. Dysregulation of RNA biology in ALS
Guillaume Hautbergue
12. New developments in pre-clinical models of ALS to guide translation
Ludo van den Bosch
